Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
- PMID: 32527654
- PMCID: PMC7247967
- DOI: 10.1016/j.dld.2020.05.037
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
Comment in
-
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre.Dig Liver Dis. 2020 Nov;52(11):1248-1249. doi: 10.1016/j.dld.2020.07.021. Epub 2020 Jul 27. Dig Liver Dis. 2020. PMID: 32811778 Free PMC article. No abstract available.
Comment on
-
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak.Dig Liver Dis. 2020 Jun;52(6):604-605. doi: 10.1016/j.dld.2020.04.004. Epub 2020 Apr 10. Dig Liver Dis. 2020. PMID: 32360133 Free PMC article.
References
-
- Zingone F., Buda A., Savarino E.V. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Dig Liver Dis. 2020 Apr 10 doi: 10.1016/j.dld.2020.04.004. pii: S1590-8658(20)30138-9[Epub ahead of print] - DOI - PMC - PubMed
-
- IOIBD Update on COVID19 for patients with crohn's disease and ulcerative colitis. IOBD. https://www.ioibd.org/ioibd-update-oncovid19-for-patients-with-crohns-di... Accessed April 12, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
